CagriSema for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 5 Nov 2026: Trial registered, NCT07919405

The trials

NCT07357766: A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

State
Withdrawn before it started
Phase
Phase 3
People
0 taking part
Started
22 Jun 2026
Primary completion
29 Nov 2027
Arms
CagriSema B in device 2 + Placebo in device 1, CagriSema in device 1 + Placebo in device 2
Results
None posted
  1. 22 Jan 2026: Trial registered
  2. 9 Jul 2026: Trial withdrawn

NCT07919405: A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

State
Not started
Phase
Phase 3
People
1,408 planned
Started
11 Nov 2026
Primary completion
1 Jun 2028
Arms
CagriSema
Results
None posted
  1. 5 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.